Moderna cuts sales forecasts for its COVID-19 vaccine
Bio Pharma Dive
NOVEMBER 3, 2022
The biotech dialed back its financial projections after reporting lower-than-expected sales for the shot, which currently remains the company’s only marketed product
Let's personalize your content